profit from every $100 of sales.
$0$100
Zhongchao
$0.98+1.38% today
-99.9% in 1 year
1-year low $0.921-year high $1,693.34
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Zhongchao sold, what it kept, and what it did with the cash.
Sales went from $14.2 million in 2022 to $11.4 million in 2025, with -$6.31 million of profit last year.
SalesProfit
Zhongchao vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Zhongchao | No profit yet | ||
 GE HealthCare Technologies | 17.9× · Fair price | ||
 Tempus AI | No profit yet | ||
 BrightSpring Health Services | 75.8× · Very expensive | ||
 HealthEquity | 39.6× · Expensive |
AI analysis
An AI analyst reads Zhongchao's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 14 | 19 | 16 | 11 | |
| 6 | 9 | 9 | 5 | |
| -3 | -5 | -0 | -6 | |
| -2 | -4 | 0 | -6 | |
| -3 | -11 | -1 | -6 | |
| -9.05 | -34.83 | -0.99 | – | |
| 44.9% | 43.8% | 56.2% | 45.0% | |
| -20.9% | -27.8% | -2.2% | -54.4% | |
| -20.8% | -58.3% | -4.1% | -55.5% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 39 | 24 | 26 | 24 |
| Cash | 12 | 8 | 8 | 8 |
| Total debt | 2 | 1 | 0 | 0 |
| Total liabilities | 6 | 3 | 2 | 2 |
| 30 | 18 | 21 | 19 | |
| 0 | 0 | 1 | – | |
| -7.4% | -22.7% | -1.3% | -26.2% | |
| -9.8% | -63.0% | -3.1% | -33.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1 | 0 | -1 | 1 | |
| 2 | 1 | 3 | 0 | |
| -3 | -1 | -5 | 1 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 0 | 0 | 0 | 4 |
Valuation
- –
- –
- –
- 0.3×
- 0.4×
- 6.2×
- –
- 16.0%
- -145.8%
- 0.0%
Profitability
- 45.0%
- -54.4%
- -55.5%
- -51.6%
- -27.1%
- -21.1%
- -32.4%
- -26.0%
- -27.2%
- 0.1%
Growth
- −7.0%
- –
- +115.3%
- –
- +82.0%
Financial health
- -1.4×
- 0.00
- 0.1%
- –
- 11.11
- 11.11
- 0.47
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 16%of 958
Bottom 6%of 888
Bottom 9%of 889
Top 3%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 24, 2026 | -1.54 | – | – |
| Sep 29, 2025 | -0.04 | – | – |
| Apr 29, 2025 | -0.16 | – | – |
| Nov 1, 2024 | 0.03 | – | – |
| May 9, 2024 | -2.54 | – | – |
| Aug 10, 2023 | -1.81 | – | – |
| Dec 31, 2022 | -1.17 | – | – |
| Sep 30, 2022 | 0.04 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
44No pass
Benjamin Graham
79Pass
Philip Fisher
30No pass
Peter Lynch
29No pass
Joel Greenblatt
0No pass
Charlie Munger
27No pass
Terry Smith
20No pass
Questions about Zhongchao
Is Zhongchao a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Zhongchao AI analysis
What does Zhongchao do?
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. It is in Medical - Healthcare Information Services.
Does Zhongchao pay a dividend?
No. Zhongchao does not pay a dividend at the moment.
Is Zhongchao stock halal?
No. Zhongchao does not pass our halal screen: its cash and confirmed interest-bearing investments are 187% of its market value, at or above the 33% limit. How we check
How has Zhongchao stock done over the past year?
Down 99.9% over the past twelve months, to $0.98. It traded between $0.92 and $1,693.34 and is 99.9% below its high.
Who are Zhongchao's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, Tempus AI, BrightSpring Health Services and HealthEquity. The peers table on this page compares their profit, growth and price with Zhongchao's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.